FI83322C - Foerfarande foer framstaellning av terapeutiskt aktiva 7',8'-dihydro-spiro/imidazolidin-4,5'-kinolin/ -2,5-dionderivat. - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiva 7',8'-dihydro-spiro/imidazolidin-4,5'-kinolin/ -2,5-dionderivat. Download PDF

Info

Publication number
FI83322C
FI83322C FI862634A FI862634A FI83322C FI 83322 C FI83322 C FI 83322C FI 862634 A FI862634 A FI 862634A FI 862634 A FI862634 A FI 862634A FI 83322 C FI83322 C FI 83322C
Authority
FI
Finland
Prior art keywords
formula
compound
hydrogen
quinoline
imidazolidine
Prior art date
Application number
FI862634A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI862634A0 (fi
FI862634A (fi
FI83322B (fi
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI862634A0 publication Critical patent/FI862634A0/fi
Publication of FI862634A publication Critical patent/FI862634A/fi
Application granted granted Critical
Publication of FI83322B publication Critical patent/FI83322B/fi
Publication of FI83322C publication Critical patent/FI83322C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI862634A 1984-10-30 1986-06-19 Foerfarande foer framstaellning av terapeutiskt aktiva 7',8'-dihydro-spiro/imidazolidin-4,5'-kinolin/ -2,5-dionderivat. FI83322C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1984/001767 WO1986002647A1 (en) 1984-10-30 1984-10-30 Spiro-heteroazolones for treatment of diabetes complications
US8401767 1984-10-30

Publications (4)

Publication Number Publication Date
FI862634A0 FI862634A0 (fi) 1986-06-19
FI862634A FI862634A (fi) 1986-06-19
FI83322B FI83322B (fi) 1991-03-15
FI83322C true FI83322C (fi) 1991-06-25

Family

ID=22182314

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862634A FI83322C (fi) 1984-10-30 1986-06-19 Foerfarande foer framstaellning av terapeutiskt aktiva 7',8'-dihydro-spiro/imidazolidin-4,5'-kinolin/ -2,5-dionderivat.

Country Status (17)

Country Link
EP (1) EP0180421B1 (el)
JP (1) JPS61109789A (el)
KR (1) KR870000625B1 (el)
AT (1) ATE66228T1 (el)
AU (1) AU553839B2 (el)
DE (1) DE3583791D1 (el)
DK (1) DK166150C (el)
ES (1) ES8704168A1 (el)
FI (1) FI83322C (el)
GR (1) GR852606B (el)
HU (1) HU198051B (el)
IE (1) IE58287B1 (el)
IL (1) IL76855A0 (el)
PH (1) PH23491A (el)
PL (2) PL152316B1 (el)
PT (1) PT81382B (el)
WO (1) WO1986002647A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537892A (en) * 1983-09-14 1985-08-27 Alcon Laboratories, Inc. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase
US4952694A (en) * 1988-07-27 1990-08-28 Pfizer Inc. Novel resolution process for racemic spiro-hydantoins
US5006657A (en) * 1988-07-27 1991-04-09 Pfizer Inc. Intermediates in a resolution process for racemic spiro hydantoins
US5037831A (en) * 1990-05-21 1991-08-06 American Home Products Corporation Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4147795A (en) * 1977-02-11 1979-04-03 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives

Also Published As

Publication number Publication date
PL255978A1 (en) 1987-07-13
PT81382B (pt) 1987-11-30
HUT40659A (en) 1987-01-28
PT81382A (en) 1985-11-01
DK495285D0 (da) 1985-10-29
PL152323B1 (en) 1990-12-31
FI862634A0 (fi) 1986-06-19
FI862634A (fi) 1986-06-19
PH23491A (en) 1989-08-16
EP0180421B1 (en) 1991-08-14
FI83322B (fi) 1991-03-15
GR852606B (el) 1986-03-04
AU4916485A (en) 1986-05-08
JPS61109789A (ja) 1986-05-28
DK166150C (da) 1993-08-09
PL152316B1 (en) 1990-12-31
IE58287B1 (en) 1993-08-25
KR860003262A (ko) 1986-05-21
ES548271A0 (es) 1987-03-16
ES8704168A1 (es) 1987-03-16
KR870000625B1 (ko) 1987-03-26
DE3583791D1 (de) 1991-09-19
DK166150B (da) 1993-03-15
IE852695L (en) 1986-04-30
HU198051B (en) 1989-07-28
EP0180421A1 (en) 1986-05-07
WO1986002647A1 (en) 1986-05-09
IL76855A0 (en) 1986-02-28
DK495285A (da) 1986-05-01
AU553839B2 (en) 1986-07-31
ATE66228T1 (de) 1991-08-15

Similar Documents

Publication Publication Date Title
EP0034063B1 (en) Hydantoin amines and pharmaceutical compositions thereof
US5066659A (en) Spiro-heteroazalones for treatment of diabetic complications
FI83322C (fi) Foerfarande foer framstaellning av terapeutiskt aktiva 7',8'-dihydro-spiro/imidazolidin-4,5'-kinolin/ -2,5-dionderivat.
EP0203791B1 (en) Spiro-imidazolidines as aldose reductase inhibitors
US5011840A (en) Imidazolidinedione derivatives in diabetes treatment
EP0159143B1 (en) Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
CA1140928A (en) Aldose reductase inhibiting quinolylhydantions
CA2089207C (en) Amphoteric tricyclic compound
EP0028485B1 (en) Spiro-imidazolones for alleviating diabetes-associated conditions, processes for preparing them, and pharmaceutical compositions containing them
PL143070B1 (en) Method of obtaining novel hidantoine derivatives
EP0136143B1 (en) Spiro-succinimides for treatment of diabetes complications
CA1292992C (en) Spiro-heteroazolones for treatment of diabetes complications
IE49659B1 (en) Spiro-quinolone hydantoins,pharmaceutical compositions containing them,and processes for their preparation
EP0306251A2 (en) Azolidinedione derivatives
KR860001870B1 (ko) 이미다졸리딘디온 유도체의 제조방법
CS244683B2 (en) Production method of spiro-3-hereroazolanes
NZ226030A (en) Spiro-azolone derivatives; pharmaceutical compositions

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: PFIZER INC.